НЕЙРОПРОТЕКТОРНОЕ ДЕЙСТВИЕ ТЕАФЛАВИНА В УСЛОВИЯХ ЭКСПЕРИМЕНТАЛЬНОГО ХРОНИЧЕСКОГО НАРУШЕНИЯ МОЗГОВОГО КРОВООБРАЩЕНИЯ

Библиографические ссылки:

Thrift AG, Thayabaranathan T, Howard G, Howard VJ, Rothwell PM, Feigin VL, Norrving B, Donnan GA, Cadilhac DA. Global stroke statistics. Int J Stroke. 2017; 12(1): 13-32.https://doi.org/10.1177/1747493016676285.

Rabinstein AA. Treatment of Acute Ischemic Stroke. Continuum (Minneap Minn). 2017; 23(1, Cerebrovascular Disease): 62-81.https://doi.org/10.1212/CON.0000000000000420..

Caprio FZ, Sorond FA. Cerebrovascular Disease: Primary and Secondary Stroke Prevention. Med Clin North Am. 2019; 103(2): 295-308.https://doi.org/10.1016/j.mcna.2018.10.001

Chamorro Á, Lo EH, Renú A, van Leyen K, Lyden PD. The future of neuroprotection in stroke. J Neurol Neurosurg Psychiatry. 2021 Feb; 92(2): 129-135.https://doi.org/10.1136/jnnp-2020-324283..

Tan Q., Peng L., Huang Y. Structure–activity relationship analysis on antioxidant and anticancer actions of Theaflavins on human colon cancer cells. J. of Agr. Food Chem. 2019; 67(1): 159–170.https://doi.org/10.1021/acs.jafc.8b05369

Grelle G, Otto A, Lorenz M, Frank RF, Wanker EE, Bieschke J. Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils. Biochemistry. 2011; 50(49): 10624-36.https://doi.org/10.1021/bi2012383.

Anandhan A, Tamilselvam K, Radhiga T, Rao S, Essa MM., Manivasagam T. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease. Brain Res. 2012; 1433: 104-13.https://doi.org/10.1016/j.brainres.2011.11.021

Wang N, Chen X, Geng D, Huang H, Zhou H. Ginkgo biloba leaf extract improves the cognitive abilities of rats with D-galactose induced dementia. J Biomed Res. 2013; 27(1): 29-36.https://doi.org/10.7555/JBR.27.20120047

Voronkov A.V., Pozdnyakov D.I., Nigaryan S.A., Khouri E.I., Miroshnichenko K.A., Sosnovskaya A.V., Olokhova E.A. Evaluation of the mitochondria respirometric function in the conditions of pathologies of various geneses. Pharmacy & Pharmacology. 2019; 7(1): 20-31.https://doi.org/10.19163/2307-9266-2019-7-1-20-31

Wang H, Huwaimel B, Verma K, Miller J, Germain T.M., Kinarivala N., Pappas D., Brookes P.S., Trippier P.C. Synthesis and Antineoplastic Evaluation of Mitochondrial Complex II (Succinate Dehydrogenase) Inhibitors Derived from Atpenin A5. ChemMedChem. 2017; 12(13): 1033-1044.https://doi.org/10.1002/cmdc.201700196.

Li Y, D'Aurelio M, Deng JH, Park JS, Manfredi G, Hu P, Lu J, Bai Y. An assembled complex IV maintains the stability and activity of complex I in mammalian mitochondria. J Biol Chem. 2007; 282(24): 17557-62.https://doi.org/10.1074/jbc.M701056200

Costa LG, Garrick JM, Roquè PJ, Pellacani C. Mechanisms of Neuroprotection by Quercetin: Counteracting Oxidative Stress and More. Oxid Med Cell Longev. 2016; 2016: 2986796.https://doi.org/10.1155/2016/2986796.

Nong Y, Huang YQ, Ju W, Kalia LV, Ahmadian G, Wang YT, Salter MW. Glycine binding primes NMDA receptor internalization. Nature. 2003; 422(6929): 302-7.https://doi.org/10.1038/nature01497..

Campos AC, Fogaça MV, Sonego AB, Guimarães FS. Cannabidiol, neuroprotection and neuropsychiatric disorders. Pharmacol Res. 2016; 112: 119-127.https://doi.org/10.1016/j.phrs.2016.01.033.

Kim JS., Lee KB., Park JH., Sung SM, Oh K., Kim EG, Chang DI, Hwang YH, Lee EJ, Kim WK, Ju C, Kim BS, Ryu JM; SAFE-TPA Investigators. Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study. Ann Neurol. 2020; 87(2): 233-245.https://doi.org/10.1002/ana.25644..

Li H, Tang Z, Chu P, Song Y, Yang Y, Sun B, Niu M, Qaed E, Shopit A, Han G, Ma X, Peng J, Hu M, Tang Z. Neuroprotective effect of phosphocreatine on oxidative stress and mitochondrial dysfunction induced apoptosis in vitro and in vivo: Involvement of dual PI3K/Akt and Nrf2/HO-1 pathways. Free Radic Biol Med. 2018; 120: 228-238.https://doi.org/10.1016/j.freeradbiomed.2018.03.014

He Z, Ning N, Zhou Q, Khoshnam SE, Farzaneh M. Mitochondria as a therapeutic target for ischemic stroke. Free Radic Biol Med. 2020; 146: 45-58.https://doi.org/10.1016/j.freeradbiomed.2019.11.005

Shi C, Fang L, Yew DT, Yao Z, Xu J. Ginkgo biloba extract EGb761 protects against mitochondrial dysfunction in platelets and hippocampi in ovariectomized rats. Platelets. 2010; 21(1): 53-9.https://doi.org/10.3109/09537100903395180..

Pereira-Caro G, Moreno-Rojas JM, Brindani N, Del Rio D, Lean MEJ, Hara Y, Crozier A. Bioavailability of Black Tea Theaflavins: Absorption, Metabolism, and Colonic Catabolism. J Agric Food Chem. 2017; 65(26): 5365-5374.https://doi.org/10.1021/acs.jafc.7b01707..

Eren-Guzelgun B, Ince E, Gurer-Orhan H. In vitro antioxidant/prooxidant effects of combined use of flavonoids. Nat Prod Res. 2018; 32(12):1446-1450.https://doi.org/10.1080/14786419.2017.1346637..

Eghbaliferiz S, Iranshahi M. Prooxidant Activity of Polyphenols, Flavonoids, Anthocyanins and Carotenoids: Updated Review of Mechanisms and Catalyzing Metals. Phytother Res. 2016; 30(9): 1379-91.https://doi.org/10.1002/ptr.5643.

Gámez A, Alva N, Carbonell T, Rama R. Extracellular ferritin contributes to neuronal injury in an in vitro model of ischemic stroke. J Physiol Biochem. 2021; 77(4): 539-545.https://doi.org/10.1007/s13105-021-00810-3.

Liu B, He W, Liu D. Functional BDNF rs7124442 Variant Regulated by miR-922 is Associated with Better Short-Term Recovery of Ischemic Stroke. Ther Clin Risk Manag. 2019; 15: 1369-1375.https://doi.org/10.2147/TCRM.S225536.

Liu Y, Zhu C, Guo J, Chen Y, Meng C. The Neuroprotective Effect of Irisin in Ischemic Stroke. Front Aging Neurosci. 2020; 12: 588958.https://doi.org/10.3389/fnagi.2020.588958..

Wei H, Sun T, Tian Y, Wang K. Ginkgolide B Modulates BDNF Expression in Acute Ischemic Stroke. J Korean Neurosurg Soc. 2017; 60(4): 391-396.https://doi.org/10.3340/jkns.2016.1010.018